NFE2L2 and central nervous system cancer: Our data showed that HACE1 post-transcriptionally upregulated NRF2 expression via an E3 ligase-independent mechanism, and demonstrated that HACE1 promoted malignant behaviors of glioma cells through activating NRF2.